{
  "nctId": "NCT03597529",
  "briefTitle": "CHOCOlate MeLatonin for AdolescenT MigrainE",
  "officialTitle": "CHOCOlate MeLatonin for AdolescenT MigrainE: The CHOCOLATE Study",
  "protocolDocument": {
    "nctId": "NCT03597529",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2018-02-05",
    "uploadDate": "2021-03-25T19:07",
    "size": 338769,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03597529/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 84,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-09-25",
    "completionDate": "2019-12-01",
    "primaryCompletionDate": "2019-12-01",
    "firstSubmitDate": "2017-06-26",
    "firstPostDate": "2018-07-24"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n1. Meet ICHD criteria for episodic migraine in children and adolescents, with at least 1 migraine attack per month on average.\n2. Age 3-17 years\n3. Dissatisfaction with previous acute treatments, for one or more of the following reasons: a) One or more previously tried acute medications have not been effective, or adequately effective, b) previously tried acute treatments have caused side effects, or C) patient/family would prefer a natural supplement for acute treatment over medication treatment\n4. If of driving age, teen participant agrees not to drive for at least 8 hours after treating with melatonin.\n\nExclusion Criteria:\n\n1. Allergy or intolerance to melatonin, or to chocolate.\n2. Opioid or barbiturate overuse as defined in ICHD\n3. Pregnant/lactating",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "3 Years",
    "maximumAge": "17 Years",
    "stdAges": [
      "CHILD"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Change in Mean Visual Analog Scale (VAS) Score",
        "description": "Visual Analog Scale (VAS) score ranges from 0-10, measured in cm, 0 indicating no pain and 10 indicating the worst pain.",
        "timeFrame": "Baseline (Time 0) and 2 hours"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 1
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 24,
    "complexityCategory": "Simple"
  },
  "collectionDate": "2025-09-22T02:29:55.033Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}